APA aipamena

Richards, R., Burls, A., & Payne, N. (2000). Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.

Chicago Style aipamena

Richards, R., A. Burls, and N. Payne. Cost Utility of Drugs for Multiple Sclerosis. Methods Used Don't Calculate True Benefit. 2000.

MLA aipamena

Richards, R., et al. Cost Utility of Drugs for Multiple Sclerosis. Methods Used Don't Calculate True Benefit. 2000.